SEC Form 4 · accession 0001563606-26-000003
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert T. Davis Jr.
Officer — EVP & President, TR&DT
Period of report
Jul 1, 2026
Accepted (ET)
Jul 6, 2026 · 4:41 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000917520
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jul 1, 2026 | A | 11,180 | A | — | — | Common Stock | 11,180 | 54,530 | D |
Explanation of responses
- F1Grant of restricted stock units ("RSUs") pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F2All RSUs reported in this row were granted under the Plan and will vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued service through such date.